Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM

Clinical trial NCT04489420 · TERMINATED

Trial details

NCT number: NCT04489420
Sponsor: Celularity Incorporated
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Astrocytoma, Grade IV Giant Cell Glioblastoma Glioblastoma Multiforme Cyclophosphamide Immunosuppressive Agents Immunologic Factors Physiological Effects of Drugs Molecular Mechanisms of Pharmacological Action Antiviral Agents Anti-infective Agents Analgesics, Non-narcotic Analgesics

Start date: 2020-10-01
Primary completion: 2021-08-10
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.